Mark S. Chambers

8.2k total citations · 1 hit paper
189 papers, 5.7k citations indexed

About

Mark S. Chambers is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology. According to data from OpenAlex, Mark S. Chambers has authored 189 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pulmonary and Respiratory Medicine, 71 papers in Otorhinolaryngology and 47 papers in Oncology. Recurrent topics in Mark S. Chambers's work include Head and Neck Cancer Studies (65 papers), Oral health in cancer treatment (65 papers) and Cancer Diagnosis and Treatment (28 papers). Mark S. Chambers is often cited by papers focused on Head and Neck Cancer Studies (65 papers), Oral health in cancer treatment (65 papers) and Cancer Diagnosis and Treatment (28 papers). Mark S. Chambers collaborates with scholars based in United States, United Kingdom and Greece. Mark S. Chambers's co-authors include Adam S. Garden, Linda S. Elting, Catherine D. Cooksley, David I. Rosenthal, James C. Lemon, Jack W. Martin, Merrill S. Kies, Scott B. Cantor, Ellen F. Manzullo and Edward Rubenstein and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark S. Chambers

186 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The burdens of cancer therapy

2003 500 citations Mark S. Chambers et al. Cancer profile →

Peers

Countries citing papers authored by Mark S. Chambers

Since Specialization

Citations

This map shows the geographic impact of Mark S. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Chambers more than expected).

Fields of papers citing papers by Mark S. Chambers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Chambers. The network helps show where Mark S. Chambers may publish in the future.

Co-authorship network of co-authors of Mark S. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Chambers. A scholar is included among the top collaborators of Mark S. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Chambers. Mark S. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck Cancer 2024 ·JAMA Network Open ·Lorenzo Cohen, Suzanne C. Danhauer, (unknown), Emily V. Dressler, David I. Rosenthal, Mark S. Chambers, (unknown), W. Mark Brown, (unknown), Peiying Yang, Joseph S. Chiang, (unknown), (unknown), Jung K. Kim, (unknown), (unknown), Mercedes Porosnicu, Kathleen J. Yost, Kathryn E. Weaver, Glenn J. Lesser	8
2	Intralesional nivolumab in oral potentially malignant disorders: A phase 1 pilot study on safety, tolerability, and preliminary efficacy. 2024 ·Journal of Clinical Oncology ·Shorook Na’ara, Dan Yaniv, (unknown), (unknown), Luana Guimarães de Sousa, (unknown), Michelle D. Williams, Jeffrey N. Myers, Mark S. Chambers, (unknown)	1
3	Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma 2024 ·Clinical Cancer Research ·Kevin J. Contrera, Renata Ferrarotto, G. Brandon Gunn, Shirley Y. Su, Merrill S. Kies, Bonnie S. Glisson, Adam S. Garden, Dianna Roberts, Curtis Hanba, (unknown), Adel K. El‐Naggar, Michelle D. Williams, Shaan M. Raza, Franco DeMonte, Melissa Chen, Mark S. Chambers, Ehab Y. Hanna	1
4	Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials 2023 ·SHILAP Revista de lepidopterología ·(unknown), Graciela M. Nogueras‐González, Yimin Geng, (unknown), Jeffrey N. Myers, Yisheng Li, Mark S. Chambers	9
5	Risk factors associated with patient‐reported fatigue among long‐term oropharyngeal carcinoma survivors 2022 ·Head & Neck ·Puja Aggarwal, Katherine A. Hutcheson, Ryan P. Goepfert, Adam S. Garden, Naveen Garg, Frank E. Mott, Clifton D. Fuller, Stephen Y. Lai, G. Brandon Gunn, Mark S. Chambers, Ehab Y. Hanna, Erich M. Sturgis, Sanjay Shete	4
6	Implementation of an International Virtual Clinical Research Course for Clinical Oncology Fellows at a Cancer Teaching Hospital in Zambia 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Kevin Diao, Dorothy Lombe, (unknown), (unknown), Rebecca S. Tidwell, Timothy A. Yap, Mark S. Chambers, Jolyn Taylor, Gwendolyn J. McGinnis, Anuja Jhingran, Laurence E. Court, Grace L. Smith, Elizabeth Y. Chiao, Carrie Cameron, Susan Msadabwe, Lilie L. Lin	1
7	Determinants of patient‐reported xerostomia among long‐term oropharyngeal cancer survivors 2021 ·Cancer ·Puja Aggarwal, Katherine A. Hutcheson, Adam S. Garden, Frank E. Mott, Charles Lu, Ryan P. Goepfert, Clifton D. Fuller, Stephen Y. Lai, G. Brandon Gunn, Mark S. Chambers, Erich M. Sturgis, Ehab Y. Hanna, Sanjay Shete	18
8	Medication-Related Osteonecrosis of the Jaw in Patients Treated Concurrently with Antiresorptive and Antiangiogenic Agents: Systematic Review and Meta-Analysis 2021 ·SHILAP Revista de lepidopterología ·(unknown), Graciela M. Nogueras‐González, Yimin Geng, (unknown), Jeffrey N. Myers, Yisheng Li, Mark S. Chambers	11
9	Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center 2020 ·Supportive Care in Cancer ·Richard C. Cardoso, Mona Kamal, Jhankruti Zaveri, Mark S. Chambers, G. Brandon Gunn, Clifton D. Fuller, Stephen Y. Lai, Frank E. Mott, (unknown), Katherine A. Hutcheson	27
10	Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck 2020 ·Cancer ·Cielito C. Reyes‐Gibby, Jian Wang, Liangliang Zhang, Christine B. Peterson, Kim‐Anh Do, Robert R. Jenq, Samuel A. Shelburne, Dimpy P. Shah, Mark S. Chambers, Ehab Y. Hanna, Sai‐Ching J. Yeung, Sanjay Shete	43
11	Reconstruction of intraoral oncologic surgical defects with Integra^® bilayer wound matrix 2020 ·SHILAP Revista de lepidopterología ·(unknown), Anastasios Maniakas, Jeffrey N. Myers, Mark S. Chambers, Richard C. Cardoso	19
12	Xerostomia Impacts Dysgeusia in Oropharyngeal Cancer Patients Treated with Proton Therapy 2019 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), G. Brandon Gunn, Clifton D. Fuller, (unknown), David I. Rosenthal, Adam S. Garden, William H. Morrison, Jack Phan, Jay P. Reddy, Erich M. Sturgis, Charles Lu, Mark S. Chambers, Katherine A. Hutcheson, (unknown), X. Zhang, (unknown), Sonja Stieb, Robert L. Foote, Steven J. Frank	1
13	Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis 2017 ·Oral Oncology ·(unknown), Stephen Y. Lai, G. Brandon Gunn, Beth M. Beadle, Clifton D. Fuller, Martha P. Barrow, Theresa M. Hofstede, Mark S. Chambers, Erich M. Sturgis, Abdallah Mohamed, Jan S. Lewin, Katherine A. Hutcheson	25
14	Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia 2015 ·Thyroid ·Mihir K. Bhayani, (unknown), (unknown), (unknown), Dianna Roberts, (unknown), Mark S. Chambers, Stephen Y. Lai	50
15	A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck 2012 ·Clinical Cancer Research ·Carol M. Lewis, Bonnie S. Glisson, Lei Feng, Fiona Wan, Ximing Tang, Ignacio I. Wistuba, Adel K. El‐Naggar, David I. Rosenthal, Mark S. Chambers, Robert A. Lustig, Randal S. Weber	131
16	Cevimeline for the Treatment of Postirradiation Xerostomia in Patients With Head and Neck Cancer 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Mark S. Chambers, Marshall R. Posner, Christopher U. Jones, Merrill A. Biel, (unknown), Robert Vitti, (unknown), Cindy F. Yen, Randal S. Weber	67
17	How to reduce radiation-related toxicity in patients with cancer of the head and neck 2006 ·Current Oncology Reports ·Adam S. Garden, Jan S. Lewin, Mark S. Chambers	19
18	Facial prosthetic rehabilitation: preprosthetic surgical techniques and biomaterials 2005 ·Current Opinion in Otolaryngology & Head & Neck Surgery ·James C. Lemon, Sudarat Kiat‐amnuay, Lawrence Gettleman, Jack W. Martin, Mark S. Chambers	73
19	Labile coodination dendrimersElectronic supplementary information (ESI) available: ESMS spectrum of 1 and dendron NMR data. See http://www.rsc.org/suppdata/cc/b1/b107658m/ 2001 ·Chemical Communications ·(unknown), E.J. MacLean, Simon J. Teat, M. Nieuwenhuyzen, Mark S. Chambers, Stuart L. James	19
20	Prosthetic Rehabilitation of Patients with Advanced Nonmelanoma Skin Cancer 1997 ·Clinics in Plastic Surgery ·James C. Lemon, Mark S. Chambers, Jack W. Martin	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact